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Reply
We thank Dr. Zheng and colleagues for their inter-
est in our study on the risk of hepatic encephalopathy
in a population-based cohort of American veterans.(1)
Zheng et al. indicated that our study included few
Asians. Given that our model was comprised of
markers of liver function (albumin and bilirubin) and
clinically significant portal hypertension (use of nonse-
lective beta-blockers) but not race, we have little reason
to suspect that the performance of this model will be
different in Asians.
Zheng et al. questioned whether the impact of sta-
tins is linked to obesity, which they posit to be more
prevalent in American patients with cirrhosis. Avail-
able data suggest that the beneficial effect of statins in
patients with portal hypertension is related to improve-
ments in vascular endothelial function and decreased
inflammatory response to gut bacteria and not to cho-
lesterol-lowering.(1) Indeed, there are data that statins
prevent decompensation in Asian patients with hepati-
tis B–related cirrhosis.(2)
Zheng et al. posit that hepatitis B may be associ-
ated with cognitive changes (which may not have
been captured in our data set).(3) To our knowledge,
evidence to support an effect of hepatitis C virus
(more prevalent in our cohort) on cognition and brain
function is more robust.(4) However, and more impor-
tantly, there are no data linking the cerebral effects of
either hepatitis B or C virus to development of
hepatic encephalopathy in patients with no cirrhosis
or increased risk of hepatic encephalopathy in those
with cirrhosis.
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